Global Health
NSE: MEDANTA · ISIN INE474Q01031 · Healthcare
₹1,425.00+27.50 (+1.97%)
Monday 9 November, 12:57 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,425.00 +27.50 (+1.97%) today
The day
- Previous close
- ₹1,397.50
- Open
- ₹1,393.40
- Day high
- ₹1,439.30
- Day low
- ₹1,390.80
Listed on NSE since 16 November 2022.
Key numbers
- Market value
- ₹37,264 Cr
- P/E (trailing)
- 60.38
- EPS (trailing)
- ₹22.98
- Price to book
- 8.63
- Dividend yield
- 0.04%
- Return on equity
- 15.2%
- Debt to equity
- 0.31
- Profit margin
- 12.2%
- Beta
- 0.23
- Volume today
- 1.52 L
- Average volume
- 2.83 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹2,682.80 Cr | ₹326.08 Cr |
| FY24 | ₹3,240.94 Cr | ₹478.19 Cr |
| FY25 | ₹3,636.68 Cr | ₹481.44 Cr |
| FY26 | ₹4,318.47 Cr | ₹556.46 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹1,469 Cr | ₹0 | −100.0% |
| Q1 FY27Apr–Jun 2026 | ₹1,304 Cr | ₹159 Cr | −0.2% |
| Q4 FY26Jan–Mar 2026Audited | ₹1,159 Cr | ₹144 Cr | +42.0% |
| Q3 FY26Oct–Dec 2025 | ₹1,121 Cr | ₹95 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹1,099 Cr | ₹158 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹1,031 Cr | ₹159 Cr | – |
Source: Global Health’s results filed with NSE, consolidated (the whole group). Net profit is the share of Global Health’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹4,144 Cr | ₹3,911 Cr |
| Investments | ₹3 Cr | ₹3 Cr |
| Inventories | ₹88 Cr | ₹79 Cr |
| Owed by customers | ₹522 Cr | ₹411 Cr |
| Cash and equivalents | ₹296 Cr | ₹127 Cr |
| Total assets | ₹6,606 Cr | ₹5,905 Cr |
| Borrowings | ₹695 Cr | ₹1,190 Cr |
| Total liabilities | ₹2,263 Cr | ₹1,921 Cr |
| Shareholders’ equity | ₹4,323 Cr | ₹3,962 Cr |
Source: Global Health’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Global Health
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
- Industry
- Medical Care Facilities
- Based in
- Gurugram
- Employees
- 12,600
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Global Health in the last day or two.
Dividends and corporate actions
All companies- Dividend - Re 0.50 Per Share
Dividend · ex-date 14 August 2026
- Dividend - Re 0.50 Per Share
Dividend · ex-date 22 August 2025
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.